Canary Speech (Provo, Utah) has launched a new product, Ambient, that provides physicians with insights about cognitive and behavioral conditions by tracking speech patterns in clinical conversations.
Provo, Utah, October 16, 2024
Canary Speech announced today the launch of Canary Ambient, an API-first solution designed for healthcare and contact centers, which offers a first-of-its-kind, real-time voice analysis during clinical conversations.
With this deployment of Canary Speech's technology, an API acts as an interface between the audio capture device (typically a physician's tablet or a smartphone) and web services from Canary. The API acts like a funnel or a tube that's feeding the platform. "Canary is at the forefront, and Ambient is the next generation of this capability," Henry O’Connell, CEO of Canary Speech, shared with TechBuzz.
"This is all happening in milliseconds," he added, explaining how AI allows Canary to perform its functions extremely quickly and in the background. "We're doing all these things using AI—diarization, speaker identification, sample, registry—from two individual speakers. We process it all in milliseconds and update it in milliseconds. It is all automated. It is happening in the background within the first 40 seconds of the conversation between the physician and the patient. It is totally non-invasive and independent. AI drives and manages all of it. No one else is doing this in the world, truthfully."
Canary Ambient's clinical decision support software enables actionable insights into patient-clinician dialogues by tracking speech patterns, and delivering immediate, real-time assessments of cognitive and behavioral health conditions of the patient.
With its advanced voice processing capabilities, Canary Ambient brings unobtrusive and impactful insights, helping organizations identify potential at-risk individuals who would benefit from further evaluation, improving overall communication and efficiency of patient care—all done unobtrusively while listening in the background.
“Canary Speech’s clinical ambient listening allows for seamless vocal biomarker analysis that captures the natural interaction between a clinician and their patient with no additional prompting required,” said Nate Blaylock, CTO of Canary Speech, based in San Antonio. “This technology supports the clinician in identifying patients who may benefit from additional screening."
“We are thrilled to offer Canary Ambient, which will allow many more organizations to frictionlessly integrate vocal biomarker analysis into existing workflows, improving patient care and customer service,” said O’Connell.
He continued, "We have the right team, right now, using advanced tools and orchestrating it to all come together in a seamless solution for healthcare." With Canary Ambient, a lot of things have come together from a technology standpoint that are allowing us to make advancements in healthcare that even three years ago were unthinkable. Even two years ago this technology wasn't available. Truly, this is a significant advancement."
Key Features of Canary Ambient include:
Canary's accuracy, which Henry O Connell mentioned as 98%, is allowing early detection of neurodegenerative disorders such as Huntington's Disease, Parkinson's Disease and Multiple Sclerosis that can be difficult to diagnose.
Regarding Multiple Sclerosis (MS), O'Connell said it is a difficult disease to diagnose. "There are a lot physiological demonstrations that we are hopeful we can identify early with our technology. When an MS patient presents to a doctor initially, it generally means they've had an episodic event. If that occurs, it usually means there has been neurological damage. If we can diagnose it early, there are at least four existing medications or therapeutics that can prevent the MS patient from ever having an an episodic event."
Canary Ambient is now available for healthcare organizations and contact centers looking to enhance their capabilities through voice-driven insights and improve the data-driven support and efficiency provided to clinicians in determining whether further assessment is necessary.
For more information on Canary Ambient, visit this page.
About Canary Speech
Canary Speech is the leading AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Canary's vocal biomarker technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression and dementia. Canary Speech is a Provo, Utah-based company that advances speech and language applications for health systems, payers and pharmaceutical markets.
To learn more about Canary Speech and their June 2024 $13 million Series A investment, see TechBuzz News' profile story.